Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
HR 124, the Byron Nash Renal Medullary Carcinoma Awareness Act of 2023, requires Medicaid to provide education about the risk of renal medullary carcinoma (a rare kidney cancer) to individuals with Sickle Cell Disease. The bill amends the Social Security Act to add "renal medullary carcinoma" to the list of conditions for which such education must be offered, alongside existing conditions like stroke. This change affects Medicaid beneficiaries diagnosed with Sickle Cell Disease, ensuring they receive specific awareness information about this cancer risk. The amendment applies to services provided on or after the bill's enactment date.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2023
Committee Review
Floor Vote
President
Introduced Jan 9, 2023
Last action Jan 20, 2023
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Jan 20, 2023
Committee
Referred to the Subcommittee on Health.
lower
Jan 9, 2023
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jan 9, 2023
Introduced
Introduced in House
lower
1 primary · 3 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Al Green
DDemocratic
Co
Bennie G. Thompson
DDemocratic
Co
Don Bacon
RRepublican
Co
Eleanor Holmes Norton
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 124
Scope: US
Hi! I can help you understand HR 124. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline